Article
Managing Azole Resistance in Aspergillus.
Medical mycology journal - 1 Jan 2026
Kushima Hisako, Ishii Hiroshi
Abstract excerpt
Azole antifungals are the cornerstone of therapy for aspergillosis, yet the global rise in azole-resistant Aspergillus fumigatus has become a major clinical concern. Resistance rates vary widely across regions, with particularly serious implications for chronic pulmonary aspergillosis (CPA), which requires long-term azole therapy. Resistance mechanisms largely involve cyp51A mutations, although additional genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
